Cheshire veterinary drugs firm sees 24% increase in profits

Ian Page, chief executive, Dechra Pharmaceuticals
Cheshire veterinary products firm Dechra saw its underlying profits increase by almost a quarter to £99.2m. The Northwich firm which acquired AST Farma and Le Vet in the Netherlands and RxVet in New Zealand has issued its preliminary results for the year. Dechra had revenue growth of 13.9% to £407.1m and underlying operating profit increased by 24.% to £99.2 million. Dechra is an international specialist veterinary pharmaceuticals and related products business. Chief executive Ian Page said: “Dechra has delivered anothe... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...